Filter by tags: Research and development Canadian Nuclear Laboratories (CNL) Clear all tag filters
1 news articles found
Canada’s particle accelerator centre, TRIUMF, and Canadian Nuclear Laboratories (CNL) have completed the first joint production run of actinium-225, a rare medical isotope that shows great promise as the basis for new, cutting-edge cancer therapies.
- Source: NEI Magazine
- Date: Wednesday, 30 October 2019
- Original article: neimagazine.com/news/newscanadian-scientists-test-technology-for-production-of-actinium-225-7478484